EUVIMEDEUVIMED entdecken
Crossref

Buprenorphine following ketamine treatment enhances anti‐suicidal effects

The Brown University Psychopharmacology Update · 2026-09 · 37 (9) · 1-5

DOI: 10.1002/pu.31484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 03.08.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with major depressive disorder (MDD) who received 4 weeks of buprenorphine treatment following a single infusion of ketamine experienced a significant reduction in suicidal ideation compared with ketamine plus placebo, a randomized, double‐blind trial has found. No serious treatment‐related adverse events were reported. Study results were published online May 19, 2026 in the American Journal of Psychiatry .

Zitieren

APA

(2026). Buprenorphine following ketamine treatment enhances anti‐suicidal effects. The Brown University Psychopharmacology Update, 37(9), 1-5. https://doi.org/10.1002/pu.31484

Vancouver

Buprenorphine following ketamine treatment enhances anti‐suicidal effects. The Brown University Psychopharmacology Update. 2026;37(9):1-5. doi:10.1002/pu.31484

BibTeX
@article{euvimed2026,
  title = {Buprenorphine following ketamine treatment enhances anti‐suicidal effects},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {9},
  pages = {1--5},
  doi = {10.1002/pu.31484}
}
Kostenlos starten →